Based on chemotaxonomic and ethno-pharmacological criteria, three Mexican plants (Jatropha dioica, Salvia texana and S. ballotaeflora) were studied for in vitro activity against HSV-1 and HSV-2. Hydro-methanolic extracts were initially evaluated for their toxicity to Vero cells. Both Salvia species displayed cytotoxicity at the lowest dose (125 µg/mL). The J. dioica extract showed only negligible cytotoxicity (CC 50 644 µg/mL). Its anti-HSV activity was evaluated using the plaque reduction assay with HSV-1 and HSV-2 (from clinical isolates) infected Vero cells. The hydro-methanolic extract of J. dioica showed IC 50 s of 280 and 370 µg/mL against HSV-1 and HSV-2, respectively. The n-hexane liquid-liquid partition of J. dioica extract contained the majority of the active principle(s) with IC 50 values of 300 and 270 µg/mL for HSV-1 and HSV-2, respectively. Bioassay-guided isolation led to the known diterpene, riolozatrione.
Herpes simplex is a global disease and the herpes virus type 1 (HSV-1) and type 2 (HSV-2) are the causative agents. HSV infections are usually serious problems among immunocompromised individuals, particularly those who are HIV-infected [1] . Among the popular plants used in Mexican herbal medicine is Jatropha dioica (Euphorbiaceae), commonly known as "tlapelex patli", "sangre de drago" or "sangre de grado". Previous studies showed the therapeutic activity of J. dioica [2, 3] and identified three diterpenes (jatropholone B, riolozatrione, citlalitrone) and β-sitosterol [4a-c] . Antiviral properties of J. curcas aqueous extract against HIV have been previously reported [5] . Additional examples of antiviral ethnobotanicals are Salvia texana, known as "salvia azul", and S. ballotaeflora, known as shrub of "salvia azul", both in the Lamiaceae family. Existing reports on S. texana concern the characterization of some flavonoids and terpenoids [6] , whereas only terpenoids have been reported from S. ballotaeflora [7] . Extracts active against herpes virus have been previously reported from the genus Salvia [8] . Based on this information, the extracts of J. dioica, S. texana, and S. ballotaeflora were evaluated for their antiviral activity against HSV-1 and HSV-2 in vitro after initial assessment of their cytotoxicity in Vero cells. Cytotoxic extracts were not followed further as the antiviral assay is performed in Vero cell culture. Serial dilutions from stock solution were made with advanced DMEM with 1% DMSO. Cells were exposed to four extract concentrations (125, 250, 500 and 1000 µg/mL), incubated for 3 days, and finally cell viability was determined by the MTT method [9a] . The CC 50 values were determined as the concentration required to produce cell death by 50% (Table 1 ). The results indicated that Salvia extracts were toxic at the lowest test concentration (CC 50 < 125 µg/mL). In contrast, the J. dioica extract showed negligible cytotoxicity with a CC 50 of 640 µg/mL and was, thus, selected for the study of it potential antiherpetic effect against HSV-1 and HSV-2 in vitro using the reduction plaque assay [9b] . For in vitro evaluation of antiviral activity, Vero cells were infected with either HSV-1 or HSV-2, and then exposed to three concentrations (125, 250 and 500 µg/mL) of the hydro-methanolic extract of J. dioica. Uninfected cells (no plaque formation), MOCK (100% plaque formation) and ACV 
640 ± 51 a 280 ± 12 b 370 ± 60 b a = data expressed as the mean value of CC 50 (µg/mL) ± SD, n=3. b = data expressed as the mean value of IC 50 (µg/mL) ± SD, n=3. 1,2 = first and second collection. ND= Not determined.
treated cells (50% of plaque reduction) were used as controls. Thus, IC 50 values of 280 and 370 µg/mL were obtained for HSV-1 and HSV-2 (Table 1 ). An intrinsic component of antiviral testing is the determination of a selectivity index (SI) towards the supporting host cell [10] . The SI for hydro-methanolic J. dioica extract, calculated as the ratio CC 50 /IC 50 , gave values of 2.3 and 1.7 for HSV-1 and HSV-2, respectively.
J. dioica hydro-methanolic extract was then subjected to liquidliquid partitioning, yielding n-hexane, ethyl acetate and n-butanol fractions, which were assessed for cytotoxic and antiviral activities ( Table 2 ). The n-hexane fraction showed higher antiviral activity and decreased the plaque formation with IC 50 values of 300 and 270 µg/mL for HSV-1 and HSV-2 respectively. The n-butanol fraction gave IC 50 s of 400 and 425 µg/mL for HSV-1 and HSV-2, respectively ( Table 2 ). The n-hexane and n-butanol partitions showed antiviral activities of 48 and 31% relative to MOCK, respectively. The SI, calculated for the n-hexane fraction, yielding 2.94 and 3.30 for HSV-1 and HSV-2, respectively. An estimated SI of 2.5 was calculated for the n-butanol partition for both viruses. As part of the bioassay-guided fractionation, the n-hexane fraction was subjected to repeated chromatographic separations to afford one major component (148 mg), identified as the known diterpene, riolozatrione [4a] , which displayed moderate antiviral activity with an IC 50 value of 66 µg/mL for both HSV-1 and HSV-2 ( Table 2 ).
These results indicate that J. dioca extract has moderate antiviral activity; further investigations of anti-herpetic compounds from the aqueous and n-butanol fractions of J. dioica are in progress. . (UAN-15925) and Jatropha dioica var. sessiliflora (Hook) (UAN-24077) were collected at Villaldama and Escobedo municipalities of Nuevo León, Mexico, and were authenticated at the Institutional Herbarium of the Biological Sciences. Voucher specimens have been deposited.
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Hydro-methanolic extracts and partitioned fractions:
Aerial parts (stem and leaves) of the Salvia plants, and roots of J. dioica were used. From each dried ground plant material, 400 g was extracted with methanol-water (90:10). The hydro-methanolic extracts were concentrated in a rotary evaporator at 37°C, yielding viscous, dark brown to gold colored residues. Partitioning was performed only for J. dioica. The hydro-methanolic extract was dissolved in 400 mL of methanol-water (90:10), and subjected to liquid-liquid extraction with n-hexane, ethyl acetate and n-butanol (3 x 100 mL each). The solvents were evaporated in a rotary evaporator at 37°C, obtaining 4 viscous brown-dark masses. For cytotoxicity and anti-herpetic activity experiments, 2 mg of each extract or partitioned fractions were dissolved in 2 mL of Advanced Dulbecco's modified Eagle's medium (DMEM) and 1% of dimethyl sulfoxide (DMSO) to give a final concentration of 1000 µg/mL.
Cell culture and virus:
Mammalian Vero cells were used for the cytotoxicity and antiviral assays. Cells were grown in Advanced DMEM media supplemented with 2% fetal bovine serum with glutamine, essential amino acids, streptomycin and 1% penicillin. Cells were maintained at 37°C in a 5% CO 2 atmosphere to reach 80% -90% confluence. HSV-1 was obtained from a clinical isolate of an infected patient at the Department of Dermatology, UANL. HSV-2 was obtained from a clinical isolate from patients attending the Dental School. Both isolates were found positive for the Herpes simplex virus thymidine kinase gene by the polymerase chain reaction (PCR) assay, as well as positive for the cytopathic effect of HSV infection in Vero cell culture.
Cytotoxicity assay: Hydro-methanolic extracts and partitioned fractions were further examined for toxicity in a mammalian Vero cell line at concentrations of 125, 250, 500 and 1000 µg/mL. After 3 days of incubation, cell viability was assessed by the Mosmann method by adding 10 µL of a solution of 5 mg/mL of 3-(4,5dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT). The CC 50 was determined as the concentration of extract required to reduce cell viability by 50%, taking as much as 100% of the untreated cells. The experiments were performed in triplicate for each extract.
Anti-herpetic assay: Briefly, 5x10 5 Vero cells were seeded onto six-well culture plates and then incubated with 100 plaque forming units (PFU) of HSV-1 or HSV-2 for 1 h, at 37°C. Supernatant was discarded and fresh medium supplemented with 1% DMSO and 0.32% of IgG was added. Concentrations of 125, 250 and 500 µg/mL for the hydro-methanolic extracts and the partitions were tested. Cells were incubated over 96 h for HSV-1 and 72 h for HSV-2. Finally, cells were fixed with methanol and stained with Giemsa reagent. Negative (MOCK) and positive (ACV) controls were used for each assay. All assays were carried out in triplicate.
